Ligand Pharmaceuticals, Inc.
(NASDAQ : LGND)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -2.19%68.000.0%$2166.19m
NVAXNovavax, Inc. 8.40%134.8796.5%$1113.01m
SRNESorrento Therapeutics, Inc. 7.74%13.371.5%$787.77m
GILDGilead Sciences, Inc. -1.21%68.011.0%$564.52m
AMGNAmgen, Inc. -0.61%240.251.3%$482.18m
REGNRegeneron Pharmaceuticals, Inc. 0.51%615.452.7%$401.22m
VRTXVertex Pharmaceuticals, Inc. -0.36%269.881.9%$366.12m
BNTXBioNTech SE 2.45%70.810.0%$359.49m
BIIBBiogen, Inc. -0.85%290.721.6%$352.51m
ILMNIllumina, Inc. 3.63%356.633.5%$350.60m
VXRTVaxart, Inc. -1.52%9.060.0%$258.53m
ATNMActinium Pharmaceuticals, Inc. -1.27%9.4313.3%$227.29m
EBSEmergent BioSolutions, Inc. 3.48%134.086.4%$194.63m
ALXNAlexion Pharmaceuticals, Inc. -0.20%102.582.0%$167.52m
SGENSeattle Genetics, Inc. 1.07%160.496.0%$160.42m

Company Profile

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.